Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional Performance

Duchenne Muscular Dystrophy Clinical Trial

Official title:

Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional Performance

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03534349
• Other study ID #: GO 16/740
• Status: Completed
• Start date: January 2017
• Est. completion date: December 2017

Study information

• Verified date: May 2018
• Source: Hacettepe University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigator investigated the effect of lower limb flexibility on functional performance of children with Duchenne Muscular Dystrophy.

Description:

Thirty children whose functional levels were in 1 or 2 according to the Brooke Lower Extremity Functional Classification Scale were included in the study. Flexibilities of hamstrings, hip flexors, tensor fascia latae, and gastrocnemius muscles were evaluated in dominant lower limb. Popliteal angle test, hip flexor flexibility test, tensor fascia latae flexibility test and gastrocnemius flexibility test were used for flexibility asssessments. Functional performance was assessed with 6 Minute Walk Test (6 MWT) and Timed Performance Tests. The correlation between the flexibility of lower limb muscles' and performance tests were examined.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: December 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 5 Years and older

Eligibility

Inclusion Criteria:

• Having a Duchenne Muscular Dystrophy diagnosis,

• Being in the ambulatory period and climbing four steps independently,

• To be able to cooperate the physiotherapist's directions,

• Not having any severe contracture in the lower limbs which may prevent assessments,

• Not having any injury or surgery involving the lower limbs during the last 6 months.

Exclusion Criteria:

Children who did not provide these criteria and did not will to participate the study were excluded.

Related Conditions & MeSH terms

• Duchenne Muscular Dystrophy
• Flexibility
• Muscular Dystrophies
• Muscular Dystrophy, Duchenne
• Performance

Locations

Country	Name	City	State
Turkey	Hacettepe University	Ankara	Sihhiye

Sponsors (1)

Lead Sponsor	Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	6 Minute Walk Test	The 6 Minute Walk Test (6MWT) is a standard test recently used to evaluate functional capacity in neuromuscular diseases, and found to be a safe and valid test that can be performed in Duchenne Muscular Dystrophy	6 Minute
Secondary	Timed Performance Test	Timed performance tests such as 10 m walk, Gower's (from supine position to stand up), ascending/descending 4 steps were also performed. During these tests, the child's performance was recorded in seconds.	3 minute